Trevi Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Trevi Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Trevi Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $973K, a 18.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $973K -$217K -18.2% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $1.03M -$212K -17.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.08M -$208K -16.1% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.14M +$1.11M +4638% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $1.19M +$1.14M +2145% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.24M +$1.16M +1413% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.29M +$1.19M +1107% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $24K -$107K -81.7% Dec 31, 2022 10-K 2024-03-20
Q3 2022 $53K -$103K -66% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $82K -$99K -54.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $107K -$97K -47.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $131K -$96K -42.3% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $156K -$94K -37.6% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $181K -$90K -33.2% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $204K -$88K -30.1% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $227K -$85K -27.2% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $250K -$81K -24.5% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $271K -$79K -22.6% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $292K -$76K -20.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $312K -$67K -17.7% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $331K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $350K Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $368K Mar 31, 2019 10-Q 2019-06-14
Q4 2018 $379K Jan 1, 2019 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.